Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals to reveal medical cannabis agreement

The halt will remain in place until Wednesday 3rd May 2017.
MGC Pharmaceuticals to reveal medical cannabis agreement
MGC has some major news pending

MGC Pharmaceuticals (ASX:MXC) is some interesting news pending with the execution of a material strategic agreement with the Royal Melbourne Institute of Technology (RMIT).

The agreement relates to the company’s Australian based medical cannabis operations, licensing and strategy.

The ASX has granted a trading halt for MGC to prepare.

The halt will remain in place until the opening of trade on Wednesday 3rd May 2017, or earlier if an announcement is made to the market.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MXC profile View Profile

MGC Pharmaceuticals Ltd Timeline

Related Articles

cannabis plan in sun
The cannabis company will manufacture, infuse and package branded recreational and wellness products
A visual representation of a drug candidate working in a dog
January 29 2019
The company has reaffirmed its upcoming milestones as it confirmed December quarter achievements.
Sydney Harbour Bridge
January 23 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use